Moncef Slaoui - Articles and news items


Major milestone for GSK/NIH candidate Ebola vaccine as first doses shipped to Liberia for use in phase III clinical trial

Industry news / 23 January 2015 / GlaxoSmithKline

GSK has announced that the first batch of its candidate Ebola vaccine is being shipped to west Africa…

GlaxoSmithKline logo

GSK launches $50 million venture capital fund to invest in pioneering bioelectronic medicines and technologies

Industry news, News / 8 August 2013 / GlaxoSmithKline

GlaxoSmithKline announced the launch of Action Potential Venture Capital (APVC) Limited…

GlaxoSmithKline logo

James Shannon named GlaxoSmithKline Chief Medical Officer

Industry news, News / 4 May 2012 / GlaxoSmithKline

James Shannon has been named GSK’s Chief Medical Officer, effective 1 May…

GlaxoSmithKline logo

GSK receives initial data from the first completed phase lll study of albiglutide in type 2 diabetes

Industry news, News / 16 November 2011 / GlaxoSmithKline

GlaxoSmithKline announced that topline results have been received…

SR one Logo 60x60

Jens Eckstein named President of SR One

Industry news, News / 7 September 2011 / GSK

Jens Eckstein has been named President of SR One, GSK’s independent healthcare venture organisation, effective 1 October…

GlaxoSmithKline logo

GSK and Human Genome Sciences receive positive opinion in Europe from the CHMP for Benlysta® (belimumab)

Industry news, News / 20 May 2011 / GlaxoSmithKline

The CHMP has issued a positive opinion, recommending marketing authorisation for Benlysta® (belimumab)…

GlaxoSmithKline to increase its shareholding in Theravance

Industry news, News / 29 November 2010 / GlaxoSmithKline

GlaxoSmithKline and Theravance, Inc. announced today that GSK will increase its shareholding in Theravance through the purchase of Theravance common stock in a private placement…


The deadline for submissions to the EPR Awards is 9 June 2017! Entry is FREE, so don't delay...